Raised HDL cholesterol in Fabry disease: Response to enzyme replacement therapy

Journal of Inherited Metabolic Disease

Volumn 27, Issue 6, 2004, Pages 791-793

  Cartwright, D J ^a   Cole, A L ^a   Cousins, A J ^a   Lee, Philip J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE BETA; ALPHA GALACTOSIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; X CHROMOSOME LINKAGE;

ADOLESCENT; ADULT; AGED; ALPHA-GALACTOSIDASE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FABRY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 7244251627     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BOLI.0000045841.27968.06     Document Type: Article

References (3)

1. Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease (2001). In: Scriver CR, Beaudet AL, Sly WS, Valle, D, eds Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3733-3774.
2. Eng CM, Guffon N, Wilcox WR, et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 345: 9-16.
3. Sacks FM (2002) The role of high density lipoprotein cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am J Cardiol 90: 139-142.